RESISTANT HYPERTENSION
Clinical trials for RESISTANT HYPERTENSION explained in plain language.
Never miss a new study
Get alerted when new RESISTANT HYPERTENSION trials appear
Sign up with your email to follow new studies for RESISTANT HYPERTENSION, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
New drug tested for stubborn high blood pressure that Won't budge
Disease control CompletedThis study tested whether a new drug called baxdrostat could help lower blood pressure in people with resistant hypertension—high blood pressure that stays high despite taking three or more medications. Over 200 participants were randomly assigned to receive either baxdrostat or …
Matched conditions: RESISTANT HYPERTENSION
Phase: PHASE3 • Sponsor: AstraZeneca • Aim: Disease control
Last updated Mar 30, 2026 14:28 UTC
-
New drug shows promise for stubborn high blood pressure
Disease control CompletedThis study tested whether a new drug called baxdrostat could help lower blood pressure in people whose high blood pressure wasn't controlled despite taking two or more medications. About 800 adults took either baxdrostat or a placebo pill daily for 12 weeks while continuing their…
Matched conditions: RESISTANT HYPERTENSION
Phase: PHASE3 • Sponsor: AstraZeneca • Aim: Disease control
Last updated Mar 27, 2026 12:38 UTC
-
New shot tested to tame stubborn high blood pressure
Disease control CompletedThis study tested a new injectable drug called XXB750 for people with resistant high blood pressure, meaning their blood pressure stays high despite taking three or more standard pills. Over 20 weeks, researchers compared different doses of XXB750 to a placebo (a dummy injection)…
Matched conditions: RESISTANT HYPERTENSION
Phase: PHASE2 • Sponsor: Novartis Pharmaceuticals • Aim: Disease control
Last updated Mar 25, 2026 14:07 UTC
-
Hidden hormone link to stubborn high blood pressure investigated in major U.S. study
Knowledge-focused CompletedThis study aimed to find out how common a hidden hormone problem (called endogenous hypercortisolism) is in people whose high blood pressure does not respond well to multiple medications. Over 1,100 adults with this 'resistant hypertension' across the U.S. were enrolled. Research…
Matched conditions: RESISTANT HYPERTENSION
Sponsor: Corcept Therapeutics • Aim: Knowledge-focused
Last updated Mar 27, 2026 12:39 UTC